368 related articles for article (PubMed ID: 21219233)
1. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
Ishimoto T; Sugihara H; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Okabe H; Hidaka K; Yokoyama N; Miyake K; Yoshikawa M; Nagano O; Komohara Y; Takeya M; Saya H; Baba H
Carcinogenesis; 2014 May; 35(5):1003-11. PubMed ID: 24318997
[TBL] [Abstract][Full Text] [Related]
3. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
[TBL] [Abstract][Full Text] [Related]
4. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
5. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
[TBL] [Abstract][Full Text] [Related]
6. Targeting miR-375 in gastric cancer.
Xu Y; Deng Y; Yan X; Zhou T
Expert Opin Ther Targets; 2011 Aug; 15(8):961-72. PubMed ID: 21557705
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as therapeutic targets and their potential applications in cancer therapy.
Cho WC
Expert Opin Ther Targets; 2012 Aug; 16(8):747-59. PubMed ID: 22690697
[TBL] [Abstract][Full Text] [Related]
8. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
Song B; Ju J
Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer.
Valladares-Ayerbes M; Blanco M; Haz M; Medina V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Reboredo M; Santamarina I; Figueroa A; Antón-Aparicio LM; Calvo L
Int J Oncol; 2011 Nov; 39(5):1253-64. PubMed ID: 21743960
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer.
Boni V; Bandres E; Zarate R; Colucci G; Maiello E; Garcia-Foncillas J
Oncology; 2009; 77 Suppl 1():75-89. PubMed ID: 20130435
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS; Dutta A
Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
[TBL] [Abstract][Full Text] [Related]
12. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
[TBL] [Abstract][Full Text] [Related]
13. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
[TBL] [Abstract][Full Text] [Related]
14. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
15. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
Blenkiron C; Miska EA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention?
Mactier KE; Glaire MA; Basavaraju U; El-Omar EM; Hold GL
Eur J Cancer Prev; 2014 Nov; 23(6):540-9. PubMed ID: 24608603
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.
Gu DN; Huang Q; Tian L
Expert Opin Ther Targets; 2015 Mar; 19(3):415-26. PubMed ID: 25434362
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and human cancer.
Nikitina EG; Urazova LN; Stegny VN
Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]